| Financial Year |
March 31 2023 |
| Monetary Funds |
1,733,214,735.71 |
| Held-for-trading Financial Assets |
766,450,935.54 |
| Notes Receivable |
891,093,397.94 |
| Accounts Receivable |
3,588,329,345.38 |
| Advances to Suppliers |
325,743,795.30 |
| Other Receivables |
219,132,821.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,695,932,451.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,805,093.75 |
| Total Current Assets |
11,137,055,290.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
993,010.84 |
| Investment Properties |
1,548,400.00 |
| Fixed Assetes |
1,264,578,165.15 |
| Under-construction Projects |
162,235,509.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
390,950,560.87 |
| R&D expenses |
-- |
| Goodwill |
806,744,752.84 |
| Long-Term Deferred and Prepaid Expenses |
45,946,420.78 |
| Deferred Income Tax Assets |
261,361,567.95 |
| Other Non-Current Assets |
150,977,262.55 |
| Sub-Total of Non-Current Assets |
4,383,687,382.92 |
| Total Assets |
15,520,742,673.67 |
| Short-Term Loans |
129,191,334.51 |
| Trading Financial liabilities |
7,568,943.00 |
| Notes Payable |
789,834,568.68 |
| Accounts Payable |
2,800,531,324.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
165,074,479.28 |
| Taxes Payable |
131,420,980.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
594,222,399.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,230,732.59 |
| Other Current Liabilities |
68,901,578.21 |
| Sub-Total of Current Liabilities |
5,537,804,640.66 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,255,076.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
49,213,842.13 |
| Deferred Income Tax Liabilities |
175,558,541.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
292,009,498.23 |
| Total Liabilities |
5,829,814,138.89 |
| Paid-In Capital(Or Share Stock) |
770,160,532.00 |
| Capital Surplus |
289,059,300.79 |
| Surplus Reserve |
383,021,391.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,556,309,710.09 |
| Minority Stockholder's Interest |
288,659,070.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,402,269,464.22 |
| Owner's Equity（Stockholder's Equity） |
9,690,928,534.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,520,742,673.67 |
